Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090495478> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3090495478 abstract "Objectives Recently, the results of two economic evaluations were published both of which seemingly demonstrate the cost-effectiveness of sofosbuvir-based regimens for the treatment of chronic hepatitis C genotype 1 infection in Germany. Both analyses were sponsored by the manufacturer of sofosbuvir and use a different methodology: Whereas one evaluation is based on a conventional cost-utility analysis, the other rests upon the efficiency-frontier method used by the German Institute for Quality and Efficiency in Health Care (IQWiG). The purpose of this study is to reanalysis the results of both economic evaluations in combination.Design Reanalysis of published decision modelling results.Setting Primary care in Germany.Participants Patients with chronic hepatitis C genotype 1 infection (treatment-naive and -experienced, cirrhotic and non-cirrhotic).Interventions Sofosbuvir, other anti-hepatitis C virus drugs, and no treatment.Primary and secondary outcome measures Cost per unit of health benefit and cost per quality-adjusted life year.Results Reanalysis of the results of both economic evaluations in combination reveals an unclear rationale for choosing the selected cost-effectiveness methods as well as a potential publication bias, favoring the product of the manufacturer. Based on the reanalysis, sofosbuvir is not cost-effective in treatment-experienced non-cirrhotic patients, potentially lacks cost-effectiveness in treatment-experienced cirrhotic patients, and is only partially cost-effective in treatment-naive non-cirrhotic patients. Taken together, these results indicate a lack of cost-effectiveness in three quarters of the German patient population.Conclusions Two economic evaluations on sofosbuvir suggest, in combination, that sofosbuvir cannot be considered a cost-effective treatment in three quarters of the German patient population." @default.
- W3090495478 created "2020-10-08" @default.
- W3090495478 creator A5080416860 @default.
- W3090495478 date "2020-10-02" @default.
- W3090495478 modified "2023-10-18" @default.
- W3090495478 title "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results" @default.
- W3090495478 cites W1498856734 @default.
- W3090495478 cites W1577435712 @default.
- W3090495478 cites W1910265541 @default.
- W3090495478 cites W2026500950 @default.
- W3090495478 cites W2034822327 @default.
- W3090495478 cites W2057825391 @default.
- W3090495478 cites W2143025931 @default.
- W3090495478 cites W2569659233 @default.
- W3090495478 cites W2588214877 @default.
- W3090495478 cites W3026743883 @default.
- W3090495478 cites W941449506 @default.
- W3090495478 doi "https://doi.org/10.1371/journal.pone.0236543" @default.
- W3090495478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7531817" @default.
- W3090495478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33006987" @default.
- W3090495478 hasPublicationYear "2020" @default.
- W3090495478 type Work @default.
- W3090495478 sameAs 3090495478 @default.
- W3090495478 citedByCount "3" @default.
- W3090495478 countsByYear W30904954782021 @default.
- W3090495478 countsByYear W30904954782022 @default.
- W3090495478 countsByYear W30904954782023 @default.
- W3090495478 crossrefType "journal-article" @default.
- W3090495478 hasAuthorship W3090495478A5080416860 @default.
- W3090495478 hasBestOaLocation W30904954781 @default.
- W3090495478 hasConcept C112930515 @default.
- W3090495478 hasConcept C138816342 @default.
- W3090495478 hasConcept C142724271 @default.
- W3090495478 hasConcept C159047783 @default.
- W3090495478 hasConcept C177713679 @default.
- W3090495478 hasConcept C2522874641 @default.
- W3090495478 hasConcept C2776125615 @default.
- W3090495478 hasConcept C2778390639 @default.
- W3090495478 hasConcept C2780040827 @default.
- W3090495478 hasConcept C3019080777 @default.
- W3090495478 hasConcept C3020491458 @default.
- W3090495478 hasConcept C524218345 @default.
- W3090495478 hasConcept C64332521 @default.
- W3090495478 hasConcept C71924100 @default.
- W3090495478 hasConceptScore W3090495478C112930515 @default.
- W3090495478 hasConceptScore W3090495478C138816342 @default.
- W3090495478 hasConceptScore W3090495478C142724271 @default.
- W3090495478 hasConceptScore W3090495478C159047783 @default.
- W3090495478 hasConceptScore W3090495478C177713679 @default.
- W3090495478 hasConceptScore W3090495478C2522874641 @default.
- W3090495478 hasConceptScore W3090495478C2776125615 @default.
- W3090495478 hasConceptScore W3090495478C2778390639 @default.
- W3090495478 hasConceptScore W3090495478C2780040827 @default.
- W3090495478 hasConceptScore W3090495478C3019080777 @default.
- W3090495478 hasConceptScore W3090495478C3020491458 @default.
- W3090495478 hasConceptScore W3090495478C524218345 @default.
- W3090495478 hasConceptScore W3090495478C64332521 @default.
- W3090495478 hasConceptScore W3090495478C71924100 @default.
- W3090495478 hasLocation W30904954781 @default.
- W3090495478 hasLocation W30904954782 @default.
- W3090495478 hasOpenAccess W3090495478 @default.
- W3090495478 hasPrimaryLocation W30904954781 @default.
- W3090495478 hasRelatedWork W12101965 @default.
- W3090495478 hasRelatedWork W12460237 @default.
- W3090495478 hasRelatedWork W12955867 @default.
- W3090495478 hasRelatedWork W15093198 @default.
- W3090495478 hasRelatedWork W17662525 @default.
- W3090495478 hasRelatedWork W21487913 @default.
- W3090495478 hasRelatedWork W2673406 @default.
- W3090495478 hasRelatedWork W364445 @default.
- W3090495478 hasRelatedWork W7601442 @default.
- W3090495478 hasRelatedWork W9008068 @default.
- W3090495478 isParatext "false" @default.
- W3090495478 isRetracted "false" @default.
- W3090495478 magId "3090495478" @default.
- W3090495478 workType "article" @default.